Subgroup analysis for prognostic and clinicopathological significance of cytoplasmic and/or nuclear β-catenin expression by its rate (≥50% vs <50%).

<p>Subgroup analysis for prognostic and clinicopathological significance of cytoplasmic and/or nuclear β-catenin expression by its rate (≥50% vs <50%).